Literature DB >> 29061682

Pearls & Oy-sters: CNS lymphoma in a patient with relapsing-remitting multiple sclerosis treated with interferon.

Sharon Chiang1, Navin K Kesari1, Anthony Bradshaw1, Wendy Chen1, Rohini Samudralwar1, Ammar M Alobaidy1, Joseph S Kass2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29061682      PMCID： PMC5664305          DOI： 10.1212/WNL.0000000000004579

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-la: analysis of data from clinical trial and post-marketing surveillance settings.

Authors:  Magnhild Sandberg-Wollheim; Gabrielle Kornmann; Dorina Bischof; Margaretha Stam Moraga; Brian Hennessy; Enrica Alteri
Journal:  Mult Scler       Date:  2011-04       Impact factor: 6.312

Review 2.  Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.

Authors:  I S Haldorsen; A Espeland; E-M Larsson
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

3.  Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.

Authors:  Samia Ragheb; Yanfeng Li; Kirk Simon; Stephen VanHaerents; Daniela Galimberti; Milena De Riz; Chiara Fenoglio; Elio Scarpini; Robert Lisak
Journal:  Mult Scler       Date:  2011-03-03       Impact factor: 6.312

4.  IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  M Rentzos; C Cambouri; A Rombos; C Nikolaou; M Anagnostouli; A Tsoutsou; A Dimitrakopoulos; N Triantafyllou; D Vassilopoulos
Journal:  J Neurol Sci       Date:  2005-11-28       Impact factor: 3.181

5.  Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications.

Authors:  B K Kleinschmidt-DeMasters; Denise M Damek; Kevin O Lillehei; Ahmed Dogan; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2008-11       Impact factor: 3.685

6.  Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.

Authors:  Hui Huang; Kouichi Ito; Fernando Dangond; Suhayl Dhib-Jalbut
Journal:  J Neuroimmunol       Date:  2013-03-13       Impact factor: 3.478

7.  The development of primary central nervous system B-cell lymphoma in multiple sclerosis.

Authors:  Mark K Lyons; Orland K Boucher; Barry D Birch; Naresh P Patel
Journal:  Neurohospitalist       Date:  2011-07

8.  Multiple sclerosis preceding CNS lymphoma: a case report.

Authors:  Jium-Han Yang; Shey-Lin Wu
Journal:  Acta Neurol Taiwan       Date:  2007-06

9.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.

Authors:  Markus Krumbholz; Diethilde Theil; Tobias Derfuss; Andreas Rosenwald; Frank Schrader; Camelia-Maria Monoranu; Susan L Kalled; Donna M Hess; Barbara Serafini; Francesca Aloisi; Hartmut Wekerle; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Exp Med       Date:  2005-01-10       Impact factor: 14.307

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.